Tutkimus

Reduction of postoperative swelling with a negative pressure treatment

In a prospective study, Saul et al. (2020) gave 45 patients a daily 30-minute LymphaTouch programme after upper extremity surgery and measured the change in swelling.

LymphaTouch handpiece on a client's upper arm

Reduction of Postoperative Swelling with a Negative Pressure Treatment – A Prospective Study

Saul, D., Fischer, A.C., Wolfgang L. & Dresing, K. 2020. Journal of Orthopaedic Surgery 28(2), 1-5. May 2020.

doi:10.1177/2309499020929166.

Purpose: Perioperative swelling and edema are the main factors that influence the time to definitive operative care, healing rate, as well as postoperative infection rate. Device-based negative pressure treatment is a new method to reduce post-traumatic and postoperative swelling of the upper extremities. The objective of this study was to evaluate a new negative pressure treatment with LymphaTouch® (Helsinki, Finland) to reduce perioperative swelling in upper extremity injuries.

Methods: We analyzed 45 patients (26 female and 19 male) after operative treatment of upper extremity injuries. A predefined treatment algorithm of 30 min using LymphaTouch® was performed on the patients every day for five consecutive days. Swelling was measured according to the neutral-zero method with six points of measurement.

Results: A total of 16 patients underwent an operation on their upper arm. An average of 3.5 measurements was performed per patient, with the start of therapy at a mean of 5.13 days after the operation. All of the measured circumferences except the elbow and 10 cm below the elbow were reduced from day 0 to 3. The percent reduction of swelling (relative to day 0) was 10.36%, 11.35%, 17.34%, and 3.25% for days 1–4, respectively. The greatest reduction of circumference was obtained in the metacarpus (51.6%) and wrist (33.1%).

Conclusion: The LymphaTouch® system and a 30-min treatment program can reduce postoperative swelling of the upper arm, wrist, and hand on the first 5 days after surgery. The ease of learning and self-applicability of LymphaTouch® makes it interesting for further controlled randomized trials.

Watch the webinar recording

Fill in your details to get instant access to the recording.

We use your details to send you the guide. Read more in our privacy policy.

Thank you! You can now watch the recording.
Watch the recording →
Something went wrong. Please check the fields and try again.